{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:11:48Z","timestamp":1770822708032,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1053\/j.ajkd.2011.10.013","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T04:58:47Z","timestamp":1323406727000},"page":"276-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Tuberous Sclerosis Complex\u2013Associated Angiomyolipomas: Focus on mTOR Inhibition"],"prefix":"10.1053","volume":"59","clinical-trial-number":[{"clinical-trial-number":"nct00126672","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00457964","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00490789","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00789828","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00790400","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Klemens","family":"Budde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Gaedeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2011.10.013_bib1","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","article-title":"Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease","volume":"24","author":"Astrinidis","year":"2005","journal-title":"Oncogene"},{"key":"10.1053\/j.ajkd.2011.10.013_bib2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00247-008-0832-y","article-title":"The pathogenesis and imaging of the tuberous sclerosis complex","volume":"38","author":"Baskin","year":"2008","journal-title":"Pediatr Radiol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2011.10.013_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.ajkd.2011.10.013_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jnnp.2003.027524","article-title":"Tuberous sclerosis complex and its founders","volume":"75","author":"Jansen","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.ajkd.2011.10.013_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1053\/j.ajkd.2011.10.013_bib7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterisation of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"10.1053\/j.ajkd.2011.10.013_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","article-title":"The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16","volume":"77","year":"1994","journal-title":"Cell"},{"key":"10.1053\/j.ajkd.2011.10.013_bib9","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1136\/jmg.37.5.e3","article-title":"Genotype-phenotype correlations in tuberous sclerosis [abstract]","volume":"37","author":"de Vries","year":"2000","journal-title":"J Med Genet"},{"key":"10.1053\/j.ajkd.2011.10.013_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1053\/j.ajkd.2011.10.013_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138920208786241243","article-title":"Genetics and molecular biology of tuberous sclerosis complex","volume":"9","author":"Napolioni","year":"2008","journal-title":"Curr Genomics"},{"key":"10.1053\/j.ajkd.2011.10.013_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Ann Hum Genet"},{"key":"10.1053\/j.ajkd.2011.10.013_bib13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev"},{"key":"10.1053\/j.ajkd.2011.10.013_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/cr.2007.64","article-title":"Expanding mTOR signaling","volume":"17","author":"Yang","year":"2007","journal-title":"Cell Res"},{"key":"10.1053\/j.ajkd.2011.10.013_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","article-title":"The TOR pathway: a target for cancer therapy","volume":"4","author":"Bjornsti","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.ajkd.2011.10.013_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1053\/j.ajkd.2011.10.013_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.ajkd.2011.10.013_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI37964","article-title":"Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade","volume":"120","author":"Ma","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2011.10.013_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1172\/JCI40221","article-title":"The evolutionarily conserved TSC\/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development","volume":"120","author":"Karbowniczek","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2011.10.013_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib21","doi-asserted-by":"crossref","first-page":"35364","DOI":"10.1074\/jbc.M205838200","article-title":"Phosphatidylinositol 3-kinase\/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin","volume":"277","author":"Dan","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2011.10.013_bib22","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2011.10.013_bib23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","article-title":"Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation","volume":"63","author":"Chan","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib24","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2011.10.013_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2011.10.013_bib27","series-title":"Clinical Dermatology","article-title":"Cutaneous manifestations of internal disease","author":"Habif","year":"2010"},{"key":"10.1053\/j.ajkd.2011.10.013_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib29","author":"Northrup"},{"key":"10.1053\/j.ajkd.2011.10.013_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O'Callaghan","year":"2004","journal-title":"BJU Int"},{"key":"10.1053\/j.ajkd.2011.10.013_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.ajkd.2011.10.013_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/1566524043359610","article-title":"The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked?","volume":"4","author":"Henske","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1053\/j.ajkd.2011.10.013_bib33","first-page":"1201","article-title":"Tuberous sclerosis-associated renal cell carcinoma","volume":"149","author":"Bjornsson","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib34","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.ajkd.2011.10.013_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","article-title":"Renal angiomyolipomata","volume":"66","author":"Bissler","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2011.10.013_bib36","first-page":"34","article-title":"Renal angiomyolipoma presenting with massive retroperitoneal hemorrhage","volume":"40","author":"Kellner","year":"2004","journal-title":"Hosp Physician"},{"key":"10.1053\/j.ajkd.2011.10.013_bib37","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ndt\/14.4.988","article-title":"End-stage renal failure in adults with the tuberous sclerosis complex","volume":"14","author":"Clarke","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2011.10.013_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1183\/09031936.96.09030402","article-title":"Extrathoracic angiomyolipomas in lymphangioleiomyomatosis","volume":"9","author":"Maziak","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1053\/j.ajkd.2011.10.013_bib39","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ajkd.2011.10.013_bib40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.ajkd.2011.10.013_bib41","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1093\/ndt\/gfm552","article-title":"Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages","volume":"22","author":"Corsenca","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2011.10.013_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor","volume":"167","author":"Lesma","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-\u03b3 in tuberous sclerosis mouse models","volume":"42","author":"Lee","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.ajkd.2011.10.013_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejim.2006.07.017","article-title":"Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex","volume":"18","author":"Herry","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1053\/j.ajkd.2011.10.013_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2011.10.013_bib46","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.ajkd.2011.10.013_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.ajkd.2011.10.013_bib48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.healun.2008.01.005","article-title":"Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment","volume":"27","author":"Morton","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.ajkd.2011.10.013_bib49","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2011.10.013_bib50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/0883073808321764","article-title":"Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex","volume":"23","author":"Koenig","year":"2008","journal-title":"J Child Neurol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611015083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638611015083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:57:42Z","timestamp":1759456662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638611015083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0272638611015083"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.10.013","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberous Sclerosis Complex\u2013Associated Angiomyolipomas: Focus on mTOR Inhibition","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}